Table 5.
Univariate analysis between patients with and without improvement in erectile function after treatment.
Improvement group | Non-improvement group | P value | |
---|---|---|---|
GH normalization after treatment (%) | 72.7% | 43.8% | 0.239 |
Post-GH (ng/ml) | 0.44 [0.15-1.03] | 2.02 [0.21-5.27] | 0.236 |
GHn normalization after treatment (%) | 88.9% | 46.7% | 0.039* |
Post-GHn (ng/ml) | 0.07 [0.03-0.12] | 1.32 [0.09-3.60] | 0.048* |
IGF-1 normalization after treatment (%) | 72.7% | 25.0% | 0.040* |
Post-IGF index | 1.03 ± 0.38 | 1.66 ± 0.95 | 0.049* |
Testosterone normalization after treatment (%) | 63.6% | 43.8% | 0.440 |
Post-Testosterone (nmol/L) | 10.56 ± 5.36 | 9.07 ± 4.43 | 0.437 |